Bipolar drug safety study halted early
NCT ID NCT06423794
First seen Jan 09, 2026 · Last updated May 23, 2026 · Updated 20 times
Summary
This study tested the long-term safety of an experimental drug called BHV-7000 in people with bipolar I disorder. It was designed for people who had already completed an earlier study of the same drug. The study was terminated early, so results are limited. Key goals were to check for serious side effects and lab abnormalities.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Advanced Research Center, Inc.
Anaheim, California, 92805, United States
-
Arch Clinical Trials
St Louis, Missouri, 63141, United States
-
Atlanta Center for Medical Research
Atlanta, Georgia, 30331, United States
-
CBH Health
Gaithersburg, Maryland, 20877, United States
-
CIT IE
Riverside, California, 92506, United States
-
CIT LA
Bellflower, California, 90706, United States
-
CenExel iResearch, LLC
Decatur, Georgia, 30030, United States
-
CenExel iResearch, LLC
Savannah, Georgia, 31405, United States
-
Cenexel - RCA
Hollywood, Florida, 33024, United States
-
Cenexel CNS
Garden Grove, California, 92845, United States
-
Cenexel CNS
Torrance, California, 90504, United States
-
Community Clinical Research, Inc.
Austin, Texas, 78754, United States
-
Floridian Neuroscience Institute
Miami Lakes, Florida, 33016, United States
-
Hassman Research Institute
Marlton, New Jersey, 08053, United States
-
InSite Clinical Research, LLC
DeSoto, Texas, 75115, United States
-
LCC Medical Research Inst
Miami, Florida, 33126, United States
-
Midwest Clinical Research Center
Dayton, Ohio, 45417, United States
-
NBCR
North Canton, Ohio, 44720, United States
-
NRC Research Institute
Orange, California, 92868, United States
-
Neuroscience Research Institute
West Palm Beach, Florida, 33407, United States
-
Pillar Clinical Research
Chicago, Illinois, 60641, United States
-
Pillar Clinical Research, LLC
Bentonville, Arkansas, 72712, United States
-
Pillar Clinical Research, LLC
Richardson, Texas, 75080, United States
-
Precise Clinical Research
Flowood, Mississippi, 39232, United States
-
ProScience Research Group
Culver City, California, 90230, United States
-
RBA
Staten Island, New York, 10329, United States
-
Segal Trials - Larkin Behavioral Health Services-Inpatient & Early Phase Site
Hollywood, Florida, 33021, United States
-
Segal Trials - Miami Lakes Medical Research-Inpatient & Early Phase Site
Miami Lakes, Florida, 33016, United States
-
Synergy San Diego
Lemon Grove, California, 91945, United States
-
Uptown Research Institute
Chicago, Illinois, 60640, United States
-
WIRG
Little Rock, Arkansas, 72211, United States
-
WRN
Rogers, Arkansas, 72758, United States
Conditions
Explore the condition pages connected to this study.